Yujie Lu

机构：Queen's University Belfast, Nanjing University of Chinese Medicine, University of Electronic Science and Technology of China, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, Sichuan Cancer Hospital, State Key Laboratory of Drug Research · ORCID：0000-0002-9630-2390

发表论文 75 篇 · 总被引 834 次 · h-index 18

代表论文

• CEMRI-Based Quantification of Intratumoral Heterogeneity for Predicting Aggressive Characteristics of Hepatocellular Carcinoma Using Habitat Analysis: Comparison and Combination of Deep Learning (2023 · Academic Radiology · 被引 43)
• Multiparametric MRI-based intratumoral and peritumoral radiomics for predicting the pathological differentiation of hepatocellular carcinoma (2024 · Insights into Imaging · 被引 41)
• Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases (2023 · British Journal of Cancer · 被引 32)
• Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation (2023 · Journal of Hepatocellular Carcinoma · 被引 17)
• Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer (2024 · Breast Cancer Research and Treatment · 被引 14)
• Ligustilide covalently binds to Cys129 of HMGCS1 to ameliorate dyslipidemia (2023 · Biomedicine & Pharmacotherapy · 被引 13)